GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Float Percentage Of Total Shares Outstanding

LAVA Therapeutics NV (LAVA Therapeutics NV) Float Percentage Of Total Shares Outstanding : 61.19% (As of Jun. 09, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LAVA Therapeutics NV's float shares is 16.09 Mil. LAVA Therapeutics NV's total shares outstanding is 26.29 Mil. LAVA Therapeutics NV's float percentage of total shares outstanding is 61.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LAVA Therapeutics NV's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LAVA Therapeutics NV's Institutional Ownership is 3.58%.


LAVA Therapeutics NV Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

LAVA Therapeutics NV's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=16.09/26.29
=61.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.